GSK3B and Alzheimer disease: Increasing evidence suggests a close association between AD and metabolic disorders such as diabetes mellitus [2,3,4], which share common pathogenic features including insulin resistance, chronic inflammation, oxidative stress, and the overactivation of glycogen synthase kinase-3β (GSK-3β) [5,6,7].